| For: | Hu HJ, Xiao XR, Li T, Liu DM, Geng X, Han M, Cui W. Integrin beta 3-overexpressing mesenchymal stromal cells display enhanced homing and can reduce atherosclerotic plaque. World J Stem Cells 2023; 15(9): 931-946 [PMID: 37900938 DOI: 10.4252/wjsc.v15.i9.931] |
|---|---|
| URL: | https://www.wjgnet.com/1948-0210/full/v15/i9/931.htm |
| Number | Citing Articles |
| 1 |
Virginia Egea. Caught in action: how MSCs modulate atherosclerotic plaque. Frontiers in Cell and Developmental Biology 2024; 12 doi: 10.3389/fcell.2024.1379091
|
| 2 |
Hana Kang, Ok-Hyeon Kim, Eun Seo Chang, Jinho Kim, Ji-Young Kim, Geun-Seup Shin, Chul-Hong Kim, Younghyun Lim, Young-Jin Seo, Jung-Woong Kim, Hyun Jung Lee. Enhanced engraftment and immunomodulatory effects of integrin alpha-2-overexpressing mesenchymal stromal cells in lipopolysaccharide-induced acute lung injury. Stem Cell Research & Therapy 2025; 16(1) doi: 10.1186/s13287-025-04423-1
|
| 3 |
Liudmila V. Kalatsei, Yana R. Sagun. Association of beta-3 integrin level with the presence and severity of coronary atherosclerosis in patients with chronic ischemic heart disease. RUDN Journal of Medicine 2024; 28(2): 142 doi: 10.22363/2313-0245-2024-28-1-142-152
|
| 4 |
Jing Zhang, Ping Wu, Qingping Wen. Optimization strategies for mesenchymal stem cell-based analgesia therapy: a promising therapy for pain management. Stem Cell Research & Therapy 2024; 15(1) doi: 10.1186/s13287-024-03828-8
|
| 5 |
Dan Liu, Jingjing Zhao, Ling Li, Jie Wang, Chao Wang, Yudong Wu, Yucun Huang, Dongming Xing, Wujun Chen. CD73: agent development potential and its application in diabetes and atherosclerosis. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1515875
|
